PubMed

United States Food and Drug Administration Approval of Neurosurgical Devices: A 25-Year Review of Non-510(k) Pathway Trends.

PMID：42419560 · 2026-07-08

A, n, d, r, e, w, , S, c, h, i, n, d, l, e, r, ;, , A, h, m, e, d, , A, b, d, o, u, ;, , P, a, r, t, h, , M, a, l, a, v, i, y, a, ;, , K, e, e, t, c, h, , M, e, c, h, a, m, ;, , S, a, m, u, e, l, , B, , K, a, n, k, a, m, ;, , P, a, r, a, s, , G, u, p, t, a, ;, , K, u, r, t, , Y, a, e, g, e, r

期刊World neurosurgery

年份2026-07-08

PMID42419560

摘要

Neurosurgical innovation increasingly relies on novel medical devices to advance the field. Low-risk devices follow the traditional 510(k) regulatory pathway for clearance; however, the U.S. Food and Drug Administration (FDA) offers other pathways; Premarket Approval (PMA), Humanitarian Device Exemption (HDE), De Novo, and Investigational Device Exemption (IDE) to provide market access for devices of different risk profiles. This study aims to provide the first characterization of non-510(k) neu

官方來源

在 PubMed 上查看 →

資料來自 PubMed / NCBI。全文與最新資訊請一律參閱官方紀錄。